Voriconazole nanopolymeric

Drug Profile

Voriconazole nanopolymeric

Alternative Names: SYP-1018; Voriconazole-loaded PNP; Voriconazole-PNP

Latest Information Update: 16 Jul 2016

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Samyang Biopharmaceuticals Corporation; Samyang Group
  • Developer Samyang Biopharmaceuticals Corporation
  • Class Antifungals; Pyrimidines; Triazoles
  • Mechanism of Action 14-alpha demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Mycoses

Highest Development Phases

  • No development reported Mycoses

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Mycoses in South Korea (IV)
  • 15 Mar 2016 Biomarkers information updated
  • 31 May 2015 Final adverse events and pharmacokinetic data from a phase I trial in healthy volunteers released by Samyang Biopharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top